TECH OUTLOOKOctober - 20201October - 05 - 2020www.pharmatechoutlook.comISSN 2644-2787EUROPE SPECIALIMMUNOTHERAPYEDITION$15INMUNOTEKJose L. Subiza, MD, PhD,President & CEOPUSHING THE BOUNDARIES OF IMMUNOTHERAPY
Page 2 >